Wenqi Dong

455 total citations
36 papers, 333 citations indexed

About

Wenqi Dong is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Wenqi Dong has authored 36 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Wenqi Dong's work include Streptococcal Infections and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Wenqi Dong is often cited by papers focused on Streptococcal Infections and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Wenqi Dong collaborates with scholars based in China, United States and Belarus. Wenqi Dong's co-authors include Chen Tan, Hao Lu, Wenjia Lu, Xishan Wang, Haiyan Dong, Gaoyan Wang, Jianfeng Xing, Yunxia Dong, Huanchun Chen and Jing Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and International Journal of Molecular Sciences.

In The Last Decade

Wenqi Dong

31 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenqi Dong China 12 140 105 105 52 40 36 333
Monika Jankute United Kingdom 10 240 1.7× 263 2.5× 218 2.1× 23 0.4× 24 0.6× 13 534
Cynthia M. Holsclaw United States 9 200 1.4× 217 2.1× 192 1.8× 27 0.5× 16 0.4× 10 404
Alice T. Bentley United States 7 157 1.1× 223 2.1× 60 0.6× 45 0.9× 26 0.7× 7 429
Sebastian Dintner Germany 11 83 0.6× 196 1.9× 33 0.3× 23 0.4× 17 0.4× 29 448
Larbi Dridi Canada 9 158 1.1× 186 1.8× 128 1.2× 18 0.3× 28 0.7× 10 413
Mugdha Srivastava Germany 13 68 0.5× 213 2.0× 83 0.8× 18 0.3× 56 1.4× 33 383
Huaiqiu Huang China 13 92 0.7× 115 1.1× 188 1.8× 23 0.4× 28 0.7× 32 405
Nicholas L. Tosini United States 5 227 1.6× 152 1.4× 130 1.2× 22 0.4× 58 1.4× 6 363
Sen Zhang China 11 62 0.4× 183 1.7× 77 0.7× 10 0.2× 50 1.3× 38 345
Sang‐Nae Cho South Korea 6 121 0.9× 112 1.1× 86 0.8× 21 0.4× 75 1.9× 7 331

Countries citing papers authored by Wenqi Dong

Since Specialization
Citations

This map shows the geographic impact of Wenqi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqi Dong more than expected).

Fields of papers citing papers by Wenqi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqi Dong. The network helps show where Wenqi Dong may publish in the future.

Co-authorship network of co-authors of Wenqi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqi Dong. A scholar is included among the top collaborators of Wenqi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqi Dong. Wenqi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Wenqi, et al.. (2025). Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence. Clinical Pharmacology & Therapeutics. 119(2). 336–349.
2.
Liu, Di, Xiaodan Li, Zhaoran Zhang, et al.. (2025). Advances in antivirulence natural products targeting the suilysin of Streptococcus suis. SHILAP Revista de lepidopterología. 5(1).
3.
Dong, Wenqi, et al.. (2025). VDAC1 Inhibition Protects Against Noise‐Induced Hearing Loss via the PINK1 /Parkin Pathway. CNS Neuroscience & Therapeutics. 31(4). e70410–e70410. 1 indexed citations
4.
Yang, Fan, Lijun Yang, Huifang Ma, et al.. (2025). Isolation and identification of Mycoplasma hyorhinis and virulence evaluation of its field isolates. Frontiers in Veterinary Science. 12. 1542992–1542992.
5.
Dong, Wenqi, Yumeng Jiang, Zhuangzhuang Li, et al.. (2025). Integrating single-cell and spatial transcriptomics reveals the cellular heterogeneity of vestibular schwannoma. npj Precision Oncology. 9(1). 228–228. 1 indexed citations
6.
Liu, Tiancai, et al.. (2024). Simultaneous Detection of Prolactin and Growth Hormone Using a Dual-label Time-resolved Fluorescence Immunoassay. Journal of Fluorescence. 35(3). 1417–1422.
7.
Zhang, Ziyi, Di Liu, Xiaodan Li, et al.. (2024). Restoring Colistin Sensitivity in Multidrug-Resistant Pathogenic E. coli Using Cinacalcet Hydrochloride. International Journal of Molecular Sciences. 25(21). 11574–11574. 2 indexed citations
8.
Dong, Wenqi, Gaoyan Wang, Jiajia Feng, et al.. (2022). MiR-25 blunts autophagy and promotes the survival of Mycobacterium tuberculosis by regulating NPC1. iScience. 25(5). 104279–104279. 15 indexed citations
9.
Wang, Shengming, Yumeng Jiang, Jingjing Wang, et al.. (2022). Single-Cell RNA-Seq Reveals Heterogeneity of Cell Communications between Schwann Cells and Fibroblasts within Vestibular Schwannoma Microenvironment. American Journal Of Pathology. 192(9). 1230–1249. 13 indexed citations
10.
Dong, Wenqi, Rui Wang, Pei Li, et al.. (2020). Orphan response regulator Rv3143 increases antibiotic sensitivity by regulating cell wall permeability in Mycobacterium smegmatis. Archives of Biochemistry and Biophysics. 692. 108522–108522. 9 indexed citations
11.
Wang, Gaoyan, Wenqi Dong, Hao Lu, et al.. (2019). Enniatin A1, A Natural Compound with Bactericidal Activity against Mycobacterium tuberculosis In Vitro. Molecules. 25(1). 38–38. 9 indexed citations
12.
Li, Pei, Rui Wang, Wenqi Dong, et al.. (2017). Comparative Proteomics Analysis of Human Macrophages Infected with Virulent Mycobacterium bovis. Frontiers in Cellular and Infection Microbiology. 7. 65–65. 25 indexed citations
13.
Chen, Shiping, Jing Sun, Xiaoliang Cheng, et al.. (2013). Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections. Journal of Antimicrobial Chemotherapy. 69(2). 463–470. 82 indexed citations
14.
Li, Zhen, Depo Yang, Colin C. Duke, & Wenqi Dong. (2011). Synthesis and MS/NMR Characterization of the Isomers of Di-hydroxylated Fatty Acid. Acta Scientiarum Naturalium Universitatis Sunyatseni. 50(5). 75. 1 indexed citations
15.
Li, Yan, Yundan Wang, Jun Luo, et al.. (2008). Production of mouse monoclonal antibodies against Helicobacter pylori Catalase and mapping the antigenic epitope by phage display library. Vaccine. 26(9). 1263–1269. 22 indexed citations
16.
Li, Yan, et al.. (2007). Production of mouse monoclonal antibodies against Helicobacter pylori Lpp20 and mapping the antigenic epitope by phage display library. Journal of Immunological Methods. 325(1-2). 1–8. 14 indexed citations
17.
Li, Yan, et al.. (2006). [Cloning, expression and identification of catalase of Helicobacter pylori].. PubMed. 22(4). 440–2, 446. 2 indexed citations
19.
Zhang, Yanming, et al.. (2003). [Cloning and expression of hepatitis C core protein gene].. PubMed. 23(10). 1018–20. 1 indexed citations
20.
Dong, Wenqi, et al.. (1991). Treating bovine hypodermiasis with the extract from dried tangerine peel. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026